All lobbying filings
BELL & LINDSAY, INC.
Lobbying for DEMERX, INC · Clinical stage drug development company
Filing
2nd Quarter - Report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$10,000.00
What the client paid this registrant for the period.
Client based in
Florida
Lobbyists on this filing
1
-
MARK F LINDSAYPreviously held: U.S House Staff
Government bodies contacted
5
Lobbying activity
1
advocacy and education around the company's value proposition to advance medicines to break the cycle of alcohol and drug dependence.